Group One Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,700
| Closed | -$2K | – | 5864 |
|
|
2018
Q1 | $2K | Sell |
10,700
-14,800
| -58% | -$13.6K | ﹤0.01% | 4680 |
|
|
2017
Q4 | $33K | Buy |
25,500
+23,500
| +1,175% | +$38.3K | ﹤0.01% | 3946 |
|
|
2017
Q3 | $4K | Sell |
2,000
-27,400
| -93% | -$66.9K | ﹤0.01% | 4570 |
|
|
2017
Q2 | $85K | Sell |
29,400
-33,500
| -53% | -$100K | ﹤0.01% | 3214 |
|
|
2017
Q1 | $216K | Buy |
62,900
+61,300
| +3,831% | +$242K | ﹤0.01% | 2477 |
|
|
2016
Q4 | $3K | Hold |
1,600
| – | – | ﹤0.01% | 4231 |
|
|
2016
Q3 | $5K | Buy |
1,600
+1,460
| +1,043% | +$5.51K | ﹤0.01% | 4244 |
|
|
2016
Q2 | $1K | Sell |
140
-50
| -26% | -$226 | ﹤0.01% | 4566 |
|
|
2016
Q1 | $1K | Sell |
190
-1,240
| -87% | -$16.1K | ﹤0.01% | 4494 |
|
|
2015
Q4 | $25K | Sell |
1,430
-42,750
| -97% | -$1.02M | ﹤0.01% | 3814 |
|
|
2015
Q3 | $932K | Buy |
44,180
+440
| +1% | +$15.1K | 0.01% | 1298 |
|
|
2015
Q2 | $2.17M | Sell |
43,740
-29,880
| -41% | -$1.79M | 0.03% | 705 |
|
|
2015
Q1 | $5.76M | Buy |
73,620
+59,180
| +410% | +$3.67M | 0.09% | 216 |
|
|
2014
Q4 | $875K | Sell |
14,440
-34,800
| -71% | -$1.75M | 0.01% | 1149 |
|
|
2014
Q3 | $2.1M | Sell |
49,240
-1,940
| -4% | -$104K | 0.03% | 655 |
|
|
2014
Q2 | $3.16M | Buy |
51,180
+14,240
| +39% | +$828K | 0.05% | 472 |
|
|
2014
Q1 | $2.4M | Buy |
36,940
+18,060
| +96% | +$1.22M | 0.04% | 537 |
|
|
2013
Q4 | $1.06M | Sell |
18,880
-870
| -4% | -$48.9K | 0.02% | 1063 |
|
|
2013
Q3 | $1.21M | Buy |
19,750
+3,410
| +21% | +$231K | 0.02% | 880 |
|
|
2013
Q2 | $956K | Buy |
+16,340
| New | +$1.01M | 0.02% | 858 |
|
Other funds holding OREX
Group One Trading's OREX Position: Q2 2018 in Review
Group One Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 38,499 shares — an estimated $8K sold.
Group One Trading first reported a position in OREX in Q2 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Group One Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Group One Trading sold 38,499 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $8K.
- Group One Trading first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 13 quarters.
- Group One Trading's Orexigen Therapeutics, Inc. position peaked at $1.78M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.